SCHEMBL30565219

SCHEMBL30565219

COc1cc(Nc2ncc(C)c(Nc3cccc(S(=O)(=O)N4CCOCC4)c3)n2)cc(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 6/20 0.55
▸ JAK2 O60674 5/20 0.55
▸ BRD4 O60885 7/20 0.54
▸ PTK6 Q13882 2/20 0.51
▸ ERBB2 P04626 2/20 0.51
▸ CDK7 P50613 2/20 0.51
▸ CDK9 P50750 2/20 0.51
▸ CDK1 P06493 2/20 0.51
▸ CDK2 P24941 2/20 0.51
▸ CCNT1 O60563 1/20 0.51
▸ CCNB1 P14635 1/20 0.51
▸ CCNA2 P20248 1/20 0.51
▸ CCNH P51946 1/20 0.51
▸ JAK3 P52333 7/20 0.51
▸ EGFR P00533 3/20 0.50
▸ BTK Q06187 3/20 0.50
▸ RET P07949 3/20 0.49
▸ WEE1 P30291 3/20 0.49
▸ FLT3 P36888 3/20 0.49
▸ ALK Q9UM73 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25381910 1.00 JAK1 (0.55) JAK1JAK2BRD4PTK6ERBB2
SCHEMBL25381155 0.92 JAK1 (0.59) JAK1JAK2BRD4CDK7CDK9
SCHEMBL31163053 0.90 BRD4 (0.56) JAK1JAK2BRD4CDK7CDK9
SCHEMBL25383250 0.84 BRD4 (0.69) JAK1JAK2BRD4PTK6CDK7
SCHEMBL30565217 0.84 BRD4 (0.69) JAK1JAK2BRD4PTK6CDK7
SCHEMBL25381831 0.84 BRD4 (0.69) JAK1JAK2BRD4PTK6CDK7
SCHEMBL30565221 0.84 BRD4 (0.69) JAK1JAK2BRD4PTK6CDK7
SCHEMBL10267648 0.84 JAK1 (0.53) JAK1JAK2BRD4CDK7CDK9
SCHEMBL270247 0.84 BRD4 (0.54) JAK1JAK2BRD4PTK6CDK7
SCHEMBL25381904 0.83 BRD4 (0.49) JAK1JAK2BRD4PTK6ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
EP-4486348-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2025-01-08 — — EP disclosed
CN-118804751-A New compounds and treatment of renal cell carcinoma 巴什生物技术公司 2024-10-18 — — CN disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
WO-2023166153-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC (US) 2023-09-07 — — WO disclosed
Send feedback